<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: There is little evidence that treatment of patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> with <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi> over periods up to 6 years results in major regression of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>AIM: To determine if longer periods of treatment with <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi> lead to significant regression of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, and to determine the incidence of oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in the <z:chebi fb="0" ids="49200">proton pump inhibitor</z:chebi>-treated patients </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We analysed prospectively-collected data on <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> patients treated with <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi> for 1-13 years </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: 188 patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath>, were treated for 1-13 years with a <z:chebi fb="0" ids="49200">proton pump inhibitor</z:chebi> (966 years of treatment; mean 5.1 years) </plain></SENT>
<SENT sid="4" pm="."><plain>No change in length was seen during treatment but 48% of patients developed squamous islands (25% after 1-3 years; 100% at 12-13 years) </plain></SENT>
<SENT sid="5" pm="."><plain>Squamous islands correlated with treatment duration and male sex but not with <z:chebi fb="0" ids="49200">proton pump inhibitor</z:chebi> dose or patient age </plain></SENT>
<SENT sid="6" pm="."><plain>Six patients developed <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and three males developed <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> during treatment (<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence 0.31%) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: <z:chebi fb="0" ids="49200">Proton-pump inhibitor</z:chebi> treatment over 1-13 years does not shorten the <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> segment but squamous islands appear in many patients </plain></SENT>
<SENT sid="8" pm="."><plain>The incidence of oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> was low in these <z:chebi fb="0" ids="49200">proton pump inhibitor</z:chebi>-treated patients compared with published series </plain></SENT>
</text></document>